Alnylam Pharmaceuticals | ALNY - PE Price to Earnings

Stock Price
335.35
Daily Change
4.11 1.24%
Monthly
-20.63%
Yearly
21.42%
Q1 Forecast
327.65

Alnylam Pharmaceuticals reported 538.03 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
Amgen USD 9.49 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Incyte USD 17.63 2.86 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
PTC Therapeutics USD 6.73 0.26 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Sanofi EUR 15.75 1.53 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Takeda JPY 235.05 184.95 Dec/2025
Tectonic Therapeutic USD 4.01 0.63 Mar/2024
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025
Xencor USD 29.92 3.22 Sep/2022